Search Results
USC, UCLA among clinical trial team behind Leqembi, the first Alzheimer's to get full FDA approval
Alzheimer’s drug Leqembi receives full FDA approval
Alzheimer's drug Leqembi receives full FDA approval
Patient in clinical trial for Alzheimer's drug, Leqembi, talks about his experience
FDA approves drug shown to slow cognitive decline in early-stage Alzheimer's patients
Dr. Emily Largent: How Do We Make Clinical Trials Better for Participants? | Live Talk
OHSU participates in trial for drug that could help prevent Alzheimer’s disease
Phase II trial of XPro1595 for the treatment of Alzheimer’s disease
Alzheimer's clinical trials in need of more Black participants
Experimental Alzheimer's drug slowed cognitive decline in clinical trial
Alzheimer's Disease & Related Disorders (ADRD), May 5, 2023, Advisory Committee Meeting
Eli Lilly says experimental drug slows Alzheimer's worsening
